High prices for orphan drugs strain families, insurers

The orphan drug program overseen by the FDA is loaded with government incentives and has helped hundreds of thousands of patients feel better or even stay alive, but the program has opened the door to almost unlimited price tags and created incentives for drug makers to cash in, and to cash in repeatedly.